Lazertinib
Catalog No.
BA6330
A potent, reversible, orally available, blood-brain barrier-crossing, mutant-selective, third-generation tyrosine kinase inhibitor.
Featured Products
Lazertinib (YH25448) is a potent, reversible, oral, blood-brain barrier-clearing, mutant-selective, third-generation tyrosine kinase inhibitor for non-small cell lung cancer.
| Physical Appearance | A solid |
| Storage | -20°C |
| M.Wt | 554.64 |
| Cas No. | 1903008-80-9 |
| Formula | C30H34N8O3 |
| Synonyms | YH25448;GNS-1480 |
| Shipping Condition | Small Molecules with Blue Ice, Modified Nucleotides with Dry Ice. |
| General tips | We do not recommend long-term storage for the solution, please use it up soon. |